U.S. flag An official website of the United States government.
Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Advisory Committee on Immunization Practices (ACIP)

CDC Stacks Public Health Publications

The ACIP is a group of medical and public health experts that develops recommendations on the use of vaccines in the civilian population of the United States. The ACIP holds three meetings each year at the Centers for Disease Control and Prevention (CDC), in Atlanta, Georgia to make vaccine recommendations. Meetings are open to the public and available online via webcast. More information on ACIP is available at: https://www.cdc.gov/vaccines/acip/index.html.

(93)
(134)
(234)
(272)
(175)
(108)
(133)
(111)
(96)
(79)
(115)
(115)
(125)
(16)
(23)
(16)
(18)
(13)
(17)
(9)
(8)
(15)
(11)
(6)
(10)
(10)
(5)
(10)
(11)
(5)
(8)
(9)
(6)
(9)
(8)
(7)
(6)
(10)
(5)
(6)
(5)
(6)
(6)
(5)
(5)
(6)
(9)
(3)
(8)
(4)
(3)
(2)
(5)
(3)
(2)
(4)
(3)
(3)
(2)
(2)
(1)
0 of 61
(12)
(32)
(108)
(35)
(11)
(1)
(1)
(48)
(48)
(49)
(7)
(1293)
(463)
(7)
0 of 14
(1)
(1)
(1)
(4)
(2)
(1)
(1)
(2)
(6)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(6)
(1)
(1)
(5)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(406)
(1)
(1)
(1)
(1)
(1)
(1)
0 of 46
(1)
(1)
(1)
0 of 3
(10)
(5)
(1)
(4)
(2)
(3)
(1)
(5)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(126)
(1)
(146)
(1)
(33)
(66)
(1)
(1)
(62)
(14)
(2)
(3)
(18)
(1)
(4)
(1)
(1)
(1)
(2)
(31)
(2)
(3)
(1)
(1)
(3)
(6)
(1)
(1)
(10)
(1)
(3)
(2)
(2)
(14)
(2)
(2)
(3)
(5)
(2)
(1)
(9)
(3)
(1)
(2)
(2)
(4)
(1)
(1)
(1)
(1)
(5)
(3)
(1)
(7)
(1)
(10)
(1)
(1)
(10)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(7)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(3)
(1)
(9)
(1)
(1)
(1)
(12)
(1)
(2)
(1)
(3)
(9)
(1)
(6)
(1)
(3)
(10)
(1)
(1)
(1)
(1)
(1)
(2)
(3)
(3)
(1)
(11)
(2)
(2)
(4)
(1)
(3)
(13)
(8)
(153)
(106)
(2)
(2)
(1)
(1)
(11)
(2)
(1)
(10)
(2)
(7)
(2)
(1)
(1)
(1)
(7)
(15)
(4)
(2)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(20)
(5)
(197)
(44)
(5)
(4)
(1)
(19)
(2)
(2)
(82)
(2)
(257)
(6)
(21)
(2)
(1)
(3)
(1)
(1)
(8)
(1)
(4)
(2)
(1)
(1)
(117)
(7)
(5)
(3)
(1)
(1)
(1)
(3)
(1)
(1)
(3)
(35)
(2)
(1)
(16)
(2)
(12)
(1)
(32)
(2)
(2)
(1)
(1)
(1)
(3)
(22)
(1)
(2)
(2)
(10)
(2)
(2)
(2)
(3)
(1)
(1)
(2)
(23)
(10)
(3)
(5)
(1)
(1)
(15)
(1)
(3)
(1)
(9)
(1)
(2)
(2)
(1)
(1)
(2)
(2)
(1)
(4)
(1)
(1)
(17)
(1)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(3)
(2)
(1)
(2)
(1)
(5)
(1)
(1)
(2)
(2)
(1)
(4)
(1)
(9)
(2)
(5)
(1)
(1)
(1)
(1)
(1)
(1)
(51)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(21)
(3)
(1)
(5)
(1)
(15)
(1)
(56)
(1)
(2)
(5)
(2)
(2)
(1)
(1)
(3)
(5)
(2)
(1)
(15)
(1)
(1)
(2)
(2)
(1)
(3)
(1)
(33)
(2)
(1)
(3)
(2)
(2)
(1)
(19)
(2)
(2)
(4)
(4)
(2)
(1)
(1)
(2)
(5)
(5)
(1)
(1)
(1)
(7)
(9)
(9)
(1)
(1)
(3)
(1)
(26)
(3)
(1)
(2)
(1)
(1)
(10)
(1)
(2)
(1)
(1)
(39)
(2)
(1)
(1)
(1)
(3)
(4)
(1)
(2)
(3)
(1)
(35)
(1)
(1)
(1)
(7)
(1)
(6)
(2)
(10)
(11)
(1)
(1)
(6)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(165)
(5)
(1)
(1)
(4)
(343)
(1)
(6)
(3)
(76)
(2)
(2)
(1)
(1)
(1)
(2)
(50)
(6)
(4)
(321)
(1)
(1)
(1)
(192)
(1)
(2)
(17)
(3)
(2)
(3)
(3)
(1)
(1)
(1)
(1)
(6)
(6)
(104)
(1)
(69)
(1)
(5)
(2)
(3)
(2)
(1)
(1)
(39)
(1)
(1)
(10)
(1)
(11)
(4)
(25)
(15)
(2)
(1)
(2)
(1)
(3)
(10)
(4)
(15)
(2)
(13)
(2)
(18)
(6)
(2)
(1)
(1)
(2)
(2)
(4)
(172)
(18)
(2)
(1)
(11)
(5)
(2)
(2)
(2)
(1)
(1)
(1)
(2)
(2)
(2)
(2)
(2)
(2)
(2)
(3)
(1)
(1)
(1)
(1)
(12)
(3)
(2)
(4)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(10)
(1)
(4)
(1)
(1)
(31)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(5)
(3)
(2)
(6)
(1)
(13)
(2)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(40)
(1)
(2)
(8)
(1)
(11)
(1)
(1)
(6)
(28)
(1)
(1)
(1)
(2)
(1)
(7)
(1)
(9)
(1)
(1)
(1)
(2)
(1)
(2)
(4)
(1)
(1)
(3)
(14)
(3)
(1)
(10)
(2)
(1)
(104)
(1)
(1)
(1)
(1)
(1)
(1)
(61)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(10)
(1)
(3)
(4)
(14)
(1)
(12)
(3)
(4)
(3)
(1)
(6)
(1)
(7)
(1)
(1)
(5)
(1)
(13)
(2)
(1)
(1)
(1)
(1)
(1)
(5)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(4)
(1)
(7)
(1)
(3)
(6)
(2)
(1)
(2)
(1)
(2)
(1)
(7)
(1)
(1)
(1)
(2)
(1)
(1)
(29)
(152)
(5)
(1)
(1)
(1)
(3)
(2)
(55)
(1)
(1)
(34)
(1)
(8)
(1)
(1)
(56)
(2)
(1)
(6)
(1)
(1)
(1)
(35)
(2)
(1)
(2)
(1)
(1)
(6)
(1)
(1)
(1)
(1)
(1)
(17)
(1)
(1)
(8)
(1)
(91)
(3)
(1)
(2)
(4)
(1)
(1)
(11)
(2)
(3)
(1)
(3)
(1)
(4)
(2)
(6)
(2)
(2)
(1)
(8)
(2)
(1)
(5)
(1)
(10)
(12)
(1)
(6)
(1)
(1)
(1)
(6)
(1)
(35)
(1)
(9)
(1)
(62)
(6)
(3)
(2)
(1)
(1)
(1)
(2)
(1)
(26)
(1)
(1)
(1)
(1)
(1)
(3)
(3)
(1)
(16)
(1)
(1)
(1)
(4)
(2)
(14)
(1)
(1)
(4)
(3)
(2)
(12)
(1)
(1)
(4)
(5)
(2)
(1)
(11)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(10)
(6)
(2)
(1)
(49)
(13)
(8)
(48)
(8)
(2)
(13)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(4)
(18)
(12)
(1)
(1)
(3)
(9)
(1)
(2)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(5)
(32)
(5)
(2)
(13)
(5)
(1)
(1)
(2)
(19)
(1)
(6)
(2)
(1)
(2)
(1)
(2)
(2)
(1)
(1)
(3)
(2)
(1)
(4)
(2)
(1)
(1)
(2)
(1)
(1)
(26)
(2)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(11)
(1)
(2)
(1)
(2)
(1)
(3)
(2)
(6)
(1)
(5)
(4)
(8)
(5)
(1)
(1)
(21)
(1)
(1)
(2)
(7)
(3)
(2)
(2)
(2)
(1)
(2)
(1)
(1)
(630)
(17)
(2)
(1)
(1)
(5)
(1)
(1)
(24)
(22)
(4)
(4)
(1)
(13)
(379)
(1)
(28)
(23)
(23)
(1)
(1)
(1)
(21)
(1)
(1)
(1)
(1)
(1)
(1)
(9)
(2)
(1)
(1)
(51)
(2)
(1)
(11)
(1)
(1)
(18)
(1)
(2)
(1)
(2)
(5)
(3)
(1)
(1)
(12)
(1)
(2)
(170)
(2)
(1)
(1)
(1)
(1)
(21)
(1)
(1)
(10)
(1)
(1)
(4)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(2)
(1)
(11)
(2)
(1)
(2)
(1)
(2)
(1)
(2)
(1)
(33)
(1)
(2)
(4)
0 of 940
(1)
(1)
(1)
(3)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(3)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(3)
(2)
(1)
(1)
(1)
(7)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(7)
(1)
(9)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(39)
(2)
(1)
(8)
(16)
(1)
(4)
(4)
(2)
(3)
(1)
(1)
(1)
(1)
(1)
(2)
(2)
(4)
(2)
(1)
(1)
(3)
(23)
(1)
(1)
(8)
(2)
(1)
(11)
(1)
(1)
(1)
(15)
(1)
(1)
(14)
(1)
(1)
(5)
(1)
(2)
(1)
(1)
(3)
(8)
(21)
(1)
(1)
(9)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(16)
(2)
(1)
(1)
(1)
(1)
(4)
(1)
(1)
(1)
(1)
(9)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(10)
(1)
(1)
(2)
(7)
(1)
(1)
(5)
(1)
(8)
(2)
(5)
(10)
(2)
(1)
(1)
(2)
(2)
(2)
(22)
(3)
(4)
(4)
(4)
(3)
(1)
(22)
(1)
(7)
(1)
(4)
(2)
(2)
(4)
(4)
(2)
(32)
(2)
(1)
(1)
(1)
(6)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(3)
(1)
(31)
(3)
(1)
(5)
(1)
(1)
(2)
(1)
(1)
(1)
(3)
(1)
(2)
(1)
(7)
(1)
(4)
(1)
(1)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(4)
(2)
(2)
(3)
(1)
(7)
(1)
(2)
(1)
(1)
(10)
(10)
(1)
(11)
(2)
(6)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(9)
(4)
(2)
(1)
(1)
(1)
(5)
(8)
(1)
(2)
(1)
(5)
(7)
(1)
(1)
(1)
(3)
(2)
(2)
(1)
(12)
(1)
(2)
(5)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(5)
(1)
(1)
(2)
(1)
(51)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(2)
(1)
(1)
(4)
(2)
(1)
(15)
(1)
(4)
(8)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(7)
(1)
(3)
(3)
(1)
(4)
(4)
(1)
(1)
(3)
(5)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(14)
(20)
(2)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(2)
(2)
(12)
(1)
(1)
(1)
(1)
(9)
(1)
(8)
(1)
(1)
(1)
(1)
(1)
(2)
(8)
(1)
(1)
(1)
(2)
(3)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(7)
(1)
(11)
(1)
(2)
(2)
(1)
(1)
(1)
(13)
(1)
(1)
(1)
(1)
(6)
(1)
(1)
(7)
(2)
(1)
(1)
(1)
(4)
(3)
(1)
(1)
(1)
(1)
(11)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(7)
(21)
(1)
(2)
(1)
(3)
(7)
(3)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(15)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(34)
(2)
(1)
(2)
(8)
(3)
(1)
(1)
(1)
(1)
(2)
(1)
(15)
(1)
(1)
(1)
(5)
(1)
(13)
(1)
(1)
(1)
(1)
(1)
(2)
(2)
(7)
(1)
(9)
(1)
(1)
(1)
(1)
(1)
(1)
(7)
(1)
(14)
(9)
(1)
(1)
(1)
(2)
(1)
(4)
(1)
(1)
(1)
(1)
(1)
(3)
(11)
(1)
(37)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(8)
(1)
(1)
(1)
(4)
(2)
(10)
(1)
(8)
(1)
(1)
(1)
(1)
(1)
(5)
(1)
(5)
(3)
(2)
(2)
(1)
(1)
(4)
(6)
(8)
(1)
(6)
(1)
(2)
(1)
(3)
(5)
(2)
(4)
(2)
(5)
(1)
(1)
(2)
(1)
(1)
(1)
(2)
(1)
(5)
(1)
(11)
(2)
(1)
(3)
(1)
(4)
(2)
(1)
(12)
(2)
(2)
(6)
(1)
(1)
(9)
(2)
(1)
(2)
(1)
(7)
(7)
(1)
(1)
(2)
(1)
(11)
(8)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(3)
(54)
(2)
(4)
(4)
(1)
(1)
(2)
(1)
(3)
(1)
(1)
(6)
(9)
(3)
(1)
(1)
(1)
(1)
(2)
(2)
(3)
(1)
(1)
(4)
(1)
(3)
(1)
(1)
(6)
(3)
(2)
(2)
(1)
(1)
(1)
(4)
(7)
(2)
(4)
(1)
(8)
(1)
(1)
(25)
(1)
(1)
(10)
(17)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(6)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(14)
(4)
(3)
(2)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(18)
(1)
(2)
(1)
(1)
(7)
(1)
(2)
(10)
(1)
(1)
(1)
(1)
(30)
(2)
(2)
(2)
(1)
(1)
(1)
(1)
(2)
(3)
(2)
(1)
(3)
(1)
(2)
(1)
(19)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(8)
(1)
(30)
(5)
(1)
(11)
(3)
(1)
(1)
(2)
(1)
(2)
(2)
(8)
(1)
(1)
(1)
(1)
(1)
(7)
(4)
(2)
(1)
(4)
(2)
(1)
(2)
(1)
(4)
(1)
(1)
(1)
(1)
(2)
(1)
(8)
(2)
(1)
(1)
(2)
(45)
(1)
(1)
(7)
(1)
(1)
(3)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(5)
(10)
(1)
(1)
(1)
(10)
(1)
(1)
(13)
(1)
(8)
(7)
(1)
(2)
(1)
(8)
(8)
(2)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(7)
(8)
(2)
(1)
(32)
(2)
(1)
(1)
(1)
(2)
(1)
(1)
(10)
(1)
(1)
(1)
(2)
(1)
(3)
(5)
(4)
(1)
(2)
(2)
(1)
(1)
(9)
(2)
(2)
(10)
(1)
(1)
(1)
(2)
(1)
(5)
(1)
(1)
(4)
(2)
(2)
(26)
(1)
(1)
(24)
(1)
(1)
(1)
(3)
(1)
(1)
(2)
(4)
(5)
(2)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(5)
(4)
(2)
(2)
(1)
(1)
(11)
(3)
(1)
(4)
(1)
(1)
(5)
(1)
(2)
(9)
(1)
(1)
(6)
(2)
(1)
(3)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
0 of 899
(2)
(1)
(1)
(3)
(1)
(1)
(2)
(2)
(5)
(24)
(3)
(4)
(6)
(1)
(16)
(21)
(9)
(1)
(1)
(1)
(1)
(6)
(3)
(1)
(4)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(3)
(1)
(8)
(1)
(3)
(6)
(1)
(1)
(2)
(14)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(29)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(2)
(50)
(113)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(9)
(1)
(1)
(1)
(5)
(1)
(1)
(1)
(1)
(1)
(6)
(1)
(1)
(2)
(2)
(9)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(2)
(4)
(1)
(1)
(1)
(5)
(1)
(11)
(1)
(2)
(1)
(1)
(4)
(2)
(1)
(1)
(1)
(1)
(4)
(2)
(1)
(1)
(1)
(6)
(1)
(1)
(8)
(1)
(2)
(7)
(5)
(1)
(1)
(5)
(2)
(6)
(1)
(1)
(1)
(12)
(1)
(9)
(2)
(1)
(5)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(5)
(4)
(3)
(4)
(1)
(16)
(11)
(1)
(8)
(6)
(1)
(3)
(1)
(5)
(1)
(3)
(25)
(3)
(8)
(1)
(1)
(1)
(30)
(4)
(6)
(1)
(12)
(34)
(30)
(1)
(1)
(1)
(4)
(1)
(1)
(1)
(9)
(1)
(10)
(14)
(2)
(10)
(1)
(90)
(1)
(1)
(1)
(1)
(1)
(1)
(7)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(46)
(4)
(3)
(2)
(66)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(83)
(1)
(1)
(1)
(2)
(53)
(1)
(1)
(1)
(4)
(1)
(1)
(1)
(3)
(2)
(6)
(9)
(1)
(10)
(1)
(1)
(2)
(3)
(6)
(2)
(1)
(5)
(4)
(1)
(3)
(2)
(1)
(1)
(13)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(10)
(1)
(22)
(3)
(7)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(2)
(4)
(1)
(1)
(1)
(4)
(9)
(1)
(2)
(1)
(1)
(1)
(3)
(1)
(2)
(3)
(3)
(1)
(2)
(10)
(1)
(6)
(1)
(1)
(11)
(1)
(1)
(1)
(1)
(3)
(1)
(7)
(1)
(1)
(1)
(1)
(1)
(13)
(1)
(14)
(547)
(1)
(1)
(1)
(6)
(1)
(3)
(1)
(4)
(10)
(1)
(15)
(11)
(14)
(1)
(4)
(4)
(1)
(2)
(2)
(5)
(1)
(4)
(1)
(162)
(1)
(5)
(1)
(3)
(7)
(3)
(1)
(33)
(2)
(14)
(3)
(3)
(9)
(2)
(1)
(10)
(1)
(2)
(30)
(6)
(1)
(4)
(4)
(5)
(2)
(7)
(1)
(6)
(2)
(1)
(19)
(15)
(1)
(1)
(9)
(5)
(1)
(2)
(2)
(18)
(3)
(5)
(46)
(2)
(1)
(2)
(3)
(2)
(1)
(3)
(4)
(1)
(5)
(1)
(1)
(4)
(3)
(1)
(1)
(7)
(2)
(2)
(3)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(3)
(7)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(10)
(3)
(2)
(3)
(1)
(1)
(1)
(5)
(1)
(1)
(1)
(1)
(1)
(11)
(1)
(1)
(1)
(3)
(1)
(2)
(1)
0 of 464
(1)
(74)
(1)
(1)
(1624)
(32)
(7)
(8)
(1)
(14)
(102)
(200)
(10)
(12)
(32)
(1295)
(1)
(18)
(2)
(2)
(38)
(1)
(1)
(1)
0 of 24
(1)
(1)
(1)
(1)
(1)
(1)
0 of 6
(1)
0 of 1
Showing 1221 - 1240 of 2154 results
  • Agenda Meeting of the Advisory Committee on Immunization Practices June 2122 2017
    [Agenda] : Meeting of the Advisory Committee on Immunization Practices, June 21-22, 2017
    United States. Advisory Committee on Immunization Practices.
    June 16, 2017 | ACIP: Meeting Agenda, Minutes, etc.
    Final - June 16, 2017Agendas 2017_6 Agenda.pdf
    Public Domain
  • Updated Recommendations for Use of MenBFHbp Serogroup B Meningococcal Vaccine Advisory Committee on Immunization Practices 2016
    Updated Recommendations for Use of MenB-FHbp Serogroup B Meningococcal Vaccine — Advisory Committee on Immunization Practices, 2016
    Patton, Monica E. ;
    Stephens, David
    May 19 2017 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    Two serogroup B meningococcal (MenB) vaccines are currently licensed for use in persons aged 10-25 years in the United States. The two vaccines are MenB-FHbp (Trumenba, Pfizer, Inc.) (1) and MenB-4C (Bexsero, GlaxoSmithKline Biologicals, Inc.) (2). In February 2015, the Advisory Committee on Immunization Practices (ACIP) recommended use of MenB vac ...
    Supporting Files Public Domain
  • Recommendations of the Advisory Committee on Immunization Practices for use of cholera vaccine
    Recommendations of the Advisory Committee on Immunization Practices for use of cholera vaccine
    Wong, Karen K. ;
    Burdette, Erin
    May 12 2017 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    Cholera, caused by infection with toxigenic Vibrio cholerae bacteria of serogroup O1 (>99% of global cases) or O139, is characterized by watery diarrhea that can be severe and rapidly fatal without prompt rehydration. Cholera is endemic in approximately 60 countries and causes epidemics as well. Globally, cholera results in an estimated 2.9 million ...
    Supporting Files Public Domain
  • Polio eradication
    Polio eradication
    Anand, Abhijeet
    22 February 2017 | ACIP: Global Immunization Updates
    Presentations February 2017 Day 1On the agenda, this presentation listed as: Global Polio Eradication Initiative.Slides from a presentation at the Advisory Committee on Immunization Practices meeting February 22-23, 2017, Atlanta, GA.global-01-anand.pdf
    Public Domain
  • General best practice guidelines for immunization best practices guidance of the Advisory Committee on Immunization Practices ACIP
    General best practice guidelines for immunization : best practices guidance of the Advisory Committee on Immunization Practices (ACIP)
    Kroger, Andrew T. ;
    Duchin, Jeffrey S.
    04/20/2017
    The Centers for Disease Control and Prevention (CDC) recommends routine vaccination to prevent 17 vaccine-preventable diseases that occur in infants, children, adolescents, or adults. This report provides information for clinicians and other health care providers about concerns that commonly arise when vaccinating persons of various ages. Providers ...
    Public Domain
  • Standards for adult immunization practice assessing implementation from provider and patient perspectives
    Standards for adult immunization practice assessing implementation from provider and patient perspectives
    Kim, David K.
    4/11/2017 | ACIP: Adult Immunization
    Presentations February 2017 DayOn the agenda, this presentation listed as: Implementation of standards for adult immunization practices.adult-02-kim.pdf
    Public Domain
  • Dengue and zika vaccines
    Dengue and zika vaccines
    Walter, Emmanuel B.
    4/11/2017 | ACIP: Dengue Virus
    Presentations February 2017 Day 2On agenda, listed as: Introduction.dengue-01-walter.pdf
    Public Domain
  • Adult Immunization Work Group Advisory Committee on Immunization Practices
    Adult Immunization Work Group, Advisory Committee on Immunization Practices
    Riley, Laura E.
    4/11/2017 | ACIP: Adult Immunization
    Presentations February 2017 Dayadult-01-riley.pdf
    Public Domain
  • Current mumps vaccination recommendations and epidemiology in the United States
    Current mumps vaccination recommendations and epidemiology in the United States
    Marin, Mona
    4/11/2017 | ACIP: Mumps
    Presentations February 2017 Day 2On agenda, listed as: Mumps epidemiology and vaccination recommendations in the United States.mumps-02-marin.pdf
    Public Domain
  • Advisory Committee on Immunization Practices ACIP Mumps Work Group
    Advisory Committee on Immunization Practices (ACIP): Mumps Work Group
    Moore, Kelly L.
    4/11/2017 | ACIP: Mumps
    Presentations February 2017 Day 2On the agenda, this presentation listed as: Introduction.mumps-01-moore.pdf
    Public Domain
  • Vaccination errors
    Vaccination errors
    Shimabukuro, Tom T.
    4/11/2017 | ACIP: Vaccination Errors
    Presentations February 2017 Day 2errors-01-shimabukuro.pdf
    Public Domain
  • Yellow fever vaccine
    Yellow fever vaccine
    Walter, Emmanuel B.
    4/11/2017 | ACIP: Yellow Fever
    Presentations February 2017 Day 2yellow-fever-01-walter.pdf
    Public Domain
  • Overview Zika vaccines in development
    Overview: Zika vaccines in development
    Kovacs, Gerald R.
    4/11/2017 | ACIP: Zika Virus
    Presentations February 2017 Day 2zika-02-kovacs.pdf
    Public Domain
  • Dengue epidemiology and vaccine development
    Dengue epidemiology and vaccine development
    Waterman, Stephen H.
    4/11/2017 | ACIP: Dengue Virus
    Presentations February 2017 Day 2dengue-02-waterman.pdf
    Public Domain
  • Agenda Meeting of the Advisory Committee on Immunization Practices February 2223 2017
    [Agenda] : Meeting of the Advisory Committee on Immunization Practices, February 22-23, 2017
    United States. Advisory Committee on Immunization Practices.
    February 8, 2017 | ACIP: Meeting Agenda, Minutes, etc.
    Final - February 8, 2017Agendas 2017_2 Agenda.pdf
    Public Domain
  • Measles and rubella elimination goals strategies and status
    Measles and rubella elimination goals, strategies and status
    Grant, Gavin B.
    4/3/2017 | ACIP: Global Immunization Updates
    Presentations February 2017 Day 1On the agenda, this presentation listed as: Global Measles/Rubella Elimination Initiative.global-02-grant.pdf
    Public Domain
  • Grading of Recommendations Assessment Development and Evaluation GRADE herpes zoster subunit vaccine
    Grading of Recommendations Assessment, Development and Evaluation (GRADE) : herpes zoster subunit vaccine
    Dooling, Kathleen
    03/31/2017 | ACIP: Herpes Zoster
    Presentations February 2017 Day 1On the agenda, this presentation listed as: GRADE of HZ/suzoster-03-dooling.pdf
    Public Domain
  • Safety summary of investigational vaccine SHINGRIX HZsu
    Safety summary of investigational vaccine : SHINGRIX* (HZ/su)
    Colindres, Romulo
    03/31/2017 | ACIP: Herpes Zoster
    Presentations February 2017 Day 1On the agenda, this presentation listed as: Safety summary of candidate vaccine, herpes zoster subunit (HZ/su)GRADE of HZ/suzoster-02-gsk.pdf
    Public Domain
  • Herpes Zoster Work Group activity update
    Herpes Zoster Work Group activity update
    Belongia, Edward A.
    03/30/2017 | ACIP: Herpes Zoster
    Presentations February 2017 Day 1On the agenda, this presentation listed as: Introduction.zoster-01-belongia.pdf
    Supporting Files Public Domain
  • Considerations for serogroup B meningococcal MenB vaccine booster doses in persons at increased risk for serogroup B meningococcal disease
    Considerations for serogroup B meningococcal (MenB) vaccine booster doses in persons at increased risk for serogroup B meningococcal disease
    MacNeil, Jessica
    3/30/2017 | ACIP: Menigococcal
    Presentations February 2017 DayOn the agenda, this presentation listed as: Considerations for MenB booster doses in groups at increased risk for serogroup B meningococcal diseasemeningococcal-02-macneil.pdf
    Public Domain
1221 - 1240 / 2154